CAR T-cell therapyB7-H3-directed CAR T-cell therapyResiquimodPOx-RmedulloblastomaG3MB
…G3MB) is the most aggressive medulloblastoma subgroup. Although CAR T-cell therapy is promising, it has shown limited efficacy in G3MB due to poor…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,881–2,940 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
anti-rheumatic treatment1anti-seizure medications1anti-snake venom therapy1anti-staphylococcal antibiotic prophylaxis1anti-thrombotic therapy1anti-tuberculosis therapy1anti-tuberculous treatment1anti-tumor necrosis factor (TNF) therapy1anti-vascular endothelial growth factor1anti-vascular endothelial growth factor (VEGF) therapies1anti-vascular endothelial growth factor treatments1antiacid treatment1antiandrogen agents1antianginal therapy1antiangiogenic therapies1antiangiogenic therapy1antiarrhythmic and anticoagulation therapy1antiarrhythmic drug therapy1antibiotic plus bowel cleansing regimens1antibiotic prevention1antibiotic regimens1antibiotic therapies1antibiotic/adjunctive treatment strategies1antibody therapies1antibody-drug conjugate (ADC) therapies1antibody-drug conjugates1anticancer immunotherapy1anticancer treatments1anticholinesterase treatment1anticoagulant/antiplatelet therapy1anticoagulated1anticoagulation reversal1anticonvulsant therapy1antidepressant medication1antidepressant prescription1antidepressant therapy1antidepressants1antidiabetes therapies1antidiabetic therapies1antiepileptic drugs1antiepileptic medication treatments1antiepileptic therapy1antiepileptic treatment1antiepileptics1antifibrotic (AF) therapy1antifibrotic medications1antifibrotic therapies1antifungal and antibacterial therapy1antiglycemic intervention1antihypertensive drugs1antimetabolite therapy1antimigraine therapies1antineoplastic drug therapies1antiparasitic therapy1antiplatelet/anticoagulant treatment1antiproliferative therapy1antiproteinuric therapy1antireflux surgery1antiresorptive therapy1antiretroviral regimens1
Articles mentioning treatments
7,227 articles · page 130 of 603RPT177Lu-PSMA-617metastatic castration-resistant prostate cancermetastatic castration-resistant prostate cancer (mCRPC)mCRPCcyclophosphamideCyNCT03873805
…stry were monitored to evaluate the efficacy and safety.Results RPT and Cy treatment alter the endogenous immune landscape in the m…
IL-12 GEMy therapyCy/FluOsteosarcomacyclophosphamiderhabdomyosarcomafludarabineNational Institutes of Health
…stasis, making it an important disease for continued studies of IL-12 GEMy therapy.Methods F42010 murine syngeneic osteosarcoma cells were orthoto…
stem cell treatmentsadoptive cell therapiesadoptive cell therapycancerantibody therapies
… drugs such as antibody therapies, adoptive cell therapies, and stem cell treatments. Understanding complex biological systems requires extensive te…
tdRT_SLNAdoptive cell therapyUniversity of California San DiegoHead and neck squamous cell carcinoma (HNSCC)Gleiberman Head and Neck Cancer CentertdRTHNSCC
…RT_SLN mice remained tumor-free for the entirety of experiment. tdRT_SLN also showed highest survival ( figure 1B-C). Data was analyzed …
E7 TCR-T cell therapyT cell receptor (TCR)-T cell therapymelanomasynovial cell sarcomasynovial sarcomahuman papillomavirus (HPV)-associated cancersNIH IRB
…vardict and strelka.Results Patient 4 had primary resistance to E7 TCR-T cell therapy due to a nonsense mutation at amino acid position 51 in the α1 …
neoadjuvant immunochemotherapyNSCLC
…e II, IIIA, and IIIB (N2) NSCLC (AJCC 8th edition) treated with neoadjuvant immunochemotherapy, with or without adjuvant therapy. Baseline characteristics, tr…
chemotherapystereotactic body radiotherapyNivolumabBiliary tract canceripilimumabPembrolizumabgemcitabineGranzyme Bcisplatin
… with chemotherapy as first-line therapy for BTC is superior to chemotherapy alone, most patients still do not benefit from treatment.2 This…
platinum chemotherapyplatinum-doublet chemotherapyanti-PD-(L)1 therapymNSCLCdocetaxelpembrolizumabvibo/pembrovibostolimab
…axel in mNSCLC previously treated with anti-PD-(L)1 therapy and platinum chemotherapy. No significant difference in PFS was observed between vibo/pem…
lymphodepleting chemotherapyLDCLEU011solid tumorssolid tumoursLEU01101ClinicalTrials.govNorth East - York Research Ethics Committee
… linear CAR. The trial hypothesis is that LEU011, combined with lymphodepleting chemotherapy (LDC), will be safe and tolerable, and will elicit efficacy in …
RPT[67Cu]Cu-LLP2Aneuroblastomasolid tumors[ 67Cu]Cu-LLP2A67Cu]Cu-LLP2Ahematological malignanciesSK-N-ASNIH institutional IACUCNB
…he tumors in both SK-N-AS and IMR-5.Conclusions [ 67Cu]Cu-LLP2A RPT improves CAR T-cell efficacy by direct tumoricidal effects and …